- Previous Close
22.15 - Open
22.05 - Bid 22.25 x --
- Ask 22.30 x --
- Day's Range
22.05 - 22.30 - 52 Week Range
20.39 - 27.72 - Volume
59,435 - Avg. Volume
162,654 - Market Cap (intraday)
2.487B - Beta (5Y Monthly) 0.11
- PE Ratio (TTM)
92.92 - EPS (TTM)
0.24 - Earnings Date --
- Forward Dividend & Yield 0.15 (0.68%)
- Ex-Dividend Date Aug 21, 2024
- 1y Target Est
--
Genovate Biotechnology Co., Ltd. operates as a specialty pharmaceutical company in Taiwan. It offers central nervous system drugs, cardiovascular drugs, musculoskeletal drugs, immune preparation drugs, anti-infective agents, anticancer drugs, anti-viral drugs, respiratory drugs, genitourinary drugs, and gastrointestinal drugs. The company manufactures active pharmaceutical ingredients, intermediates, controlled release medicine, and cosmetic products. Genovate Biotechnology Co., Ltd. was founded in 1982 and is based in Hsinchu City, Taiwan.
www.genovate-bio.comRecent News: 4130.TWO
View MorePerformance Overview: 4130.TWO
Trailing total returns as of 10/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4130.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4130.TWO
View MoreValuation Measures
Market Cap
2.47B
Enterprise Value
1.93B
Trailing P/E
91.26
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.78
Price/Book (mrq)
1.64
Enterprise Value/Revenue
3.70
Enterprise Value/EBITDA
28.19
Financial Highlights
Profitability and Income Statement
Profit Margin
5.22%
Return on Assets (ttm)
1.03%
Return on Equity (ttm)
1.83%
Revenue (ttm)
522.76M
Net Income Avi to Common (ttm)
27.3M
Diluted EPS (ttm)
0.24
Balance Sheet and Cash Flow
Total Cash (mrq)
538.6M
Total Debt/Equity (mrq)
0.20%
Levered Free Cash Flow (ttm)
48.44M